Meloxicam is hardest on the stomach and digestive tract, though it also poses real risks to the kidneys, heart, and liver. As a nonsteroidal anti-inflammatory drug (NSAID), meloxicam works by blocking enzymes that produce inflammation, but those same enzymes protect the lining of your stomach, maintain blood flow to your kidneys, and help regulate cardiovascular function. The organ most likely to give you trouble depends on your dose, how long you take it, and what other health conditions or medications are in the picture.
The Stomach and GI Tract Take the Biggest Hit
The gastrointestinal system is where meloxicam causes the most frequent problems. NSAIDs reduce the production of protective compounds that keep your stomach lining intact, leaving it vulnerable to irritation, ulcers, and bleeding. According to FDA labeling data, about 1% of patients treated for three to six months develop upper GI ulcers, significant bleeding, or perforation. That number climbs to 2 to 4% after a full year of use, and the risk keeps rising the longer you stay on the drug.
Meloxicam does have a modest advantage here compared to older NSAIDs like ibuprofen or diclofenac. Because it preferentially blocks COX-2 (the enzyme tied to inflammation) over COX-1 (the enzyme that protects the stomach), it causes roughly 36% fewer GI side effects and about half the rate of ulcers, perforations, and GI bleeds compared to less selective NSAIDs. That’s a meaningful difference, but it doesn’t eliminate the risk. Stomach damage from meloxicam can happen without warning symptoms, especially in older adults.
Kidney Risks Rise With Certain Conditions
Your kidneys rely on prostaglandins to maintain adequate blood flow, particularly when you’re dehydrated, elderly, or already dealing with reduced kidney function. Meloxicam suppresses prostaglandin production, which can reduce blood flow to the kidneys and lower your glomerular filtration rate, the measure of how efficiently your kidneys filter waste. In a person with healthy kidneys and normal hydration, this effect is usually minimal. The trouble starts when kidneys are already under stress.
One animal study found that meloxicam, unlike several other NSAIDs, did not significantly affect sodium or potassium excretion in the kidneys, likely because it reaches lower concentrations in kidney tissue. That’s a relative advantage, but it doesn’t make meloxicam kidney-safe for everyone. Older adults with compromised kidney function can still experience meaningful drops in filtration and sodium excretion.
The risk jumps dramatically when meloxicam is combined with certain common medications. A well-documented pattern called the “triple whammy” occurs when an NSAID is taken alongside a blood pressure drug (like an ACE inhibitor or angiotensin receptor blocker) and a diuretic. This combination significantly impairs kidney function, particularly in elderly patients. Studies show a clear, dose-dependent deterioration in kidney clearance as more of these drugs are stacked together.
Cardiovascular Risk Starts Early
All non-aspirin NSAIDs, meloxicam included, carry a boxed warning from the FDA for increased risk of heart attack and stroke. This isn’t a theoretical concern limited to long-term users. Observational studies have found elevated cardiovascular risk within days to weeks of starting an NSAID. The risk increases with higher doses and longer use, with estimates ranging from a 10 to 50% increased chance of a serious cardiovascular event depending on the drug and dose.
Clinical trials lasting up to three years have confirmed this pattern for both COX-2 selective and nonselective NSAIDs. For people with existing heart disease, the stakes are even higher. A large Danish registry study found that NSAID use in patients with heart failure increased the risk of heart attack, hospitalization for heart failure, and death. If you have a history of heart disease, high blood pressure, or stroke, meloxicam amplifies those existing risks.
Liver Damage Is Rare but Possible
The liver processes meloxicam, and in prospective studies, up to 7% of patients experienced at least a temporary rise in liver enzymes. Most of these elevations were mild and resolved on their own. About 1% of patients had enzyme levels climb above three times the normal upper limit, which is the threshold where clinicians start paying closer attention.
Actual liver injury with jaundice from meloxicam is rare, limited to individual case reports rather than patterns in large studies. When it does occur, symptoms typically appear within one to five weeks of starting the drug. The damage can follow different patterns, sometimes affecting bile flow (cholestatic) and sometimes directly injuring liver cells (hepatocellular). The severity ranges from lab abnormalities you’d never feel to full symptomatic hepatitis with yellowing of the skin.
Who Faces the Most Risk
Several factors push the risk higher across all of these organs. Age is the single biggest one. Older adults have less reserve in their kidneys, thinner stomach linings, and a higher likelihood of cardiovascular disease. People with pre-existing kidney disease, liver disease, heart failure, high blood pressure, high potassium levels, or a history of stomach ulcers or bleeding face amplified risks. Severe kidney disease is a specific contraindication for certain meloxicam formulations.
The combination of medications matters enormously. Beyond the triple whammy with blood pressure drugs and diuretics, taking meloxicam alongside blood thinners or corticosteroids further increases the chance of GI bleeding. Even over-the-counter NSAIDs like ibuprofen, if taken alongside meloxicam, stack the same risks.
How to Reduce Organ Stress
The FDA’s guidance is straightforward: use the lowest effective dose for the shortest possible time. The maximum daily dose of meloxicam is 15 mg, but many people manage their symptoms at 7.5 mg. Every step down in dose and duration reduces the cumulative risk to your stomach, kidneys, and heart.
Signs that meloxicam may be affecting your organs include dark or tarry stools, stomach pain, nausea, unusual fatigue, swelling in the legs or ankles, decreased urination, unexplained weight gain, dark urine, or yellowing of the skin or eyes. Swelling and reduced urine output point toward kidney stress. Dark stools or stomach pain suggest GI bleeding. Yellowing skin signals liver involvement. Sudden chest pain, shortness of breath, weakness on one side of the body, or slurred speech are cardiovascular emergencies regardless of what medication you’re taking.